389850-21-9

389850-21-9 structure

Name: 2-Amino-3-[2-(4-nitrophenyl)-2-oxoethyl]-4,5,6,7-tetrahydro-1,3-benzothiazol-3-ium bromide
Chemical Name: 2-Amino-3-[2-(4-nitrophenyl)-2-oxoethyl]-4,5,6,7-tetrahydro-1,3-benzothiazol-3-ium bromide
CAS Number: 389850-21-9
Molecular Formula: C₁₅H₁₆BrN₃O₃S
Molecular Weight: 398.275
Catalog: Signaling Pathways Apoptosis Caspase
Create Date: 2018-01-04 19:41:23
Modify Date: 2025-08-25 18:28:15
p-nitro-Pifithrin-α, a cell-permeable analog of pifithrin-α, is a potent p53 inhibitor. p-nitro-Pifithrin-α suppresses p53-mediated TGF-β1 expression in HK-2 cells. p-nitro-Pifithrin-α inhibits the activation of caspase-3 by Zika virus (ZIKV) strains. p-nitro-Pifithrin-α attenuates steatosis and liver injury in mice fed a high-fat diet [4].non-alcoholic fatty liver disease[1][2][3].

Name	2-Amino-3-[2-(4-nitrophenyl)-2-oxoethyl]-4,5,6,7-tetrahydro-1,3-benzothiazol-3-ium bromide
Synonyms	Benzothiazolium, 2-amino-4,5,6,7-tetrahydro-3-[2-(4-nitrophenyl)-2-oxoethyl]-, bromide (1:1) 2-Amino-3-[2-(4-nitrophenyl)-2-oxoethyl]-4,5,6,7-tetrahydro-1,3-benzothiazol-3-ium bromide

Description	p-nitro-Pifithrin-α, a cell-permeable analog of pifithrin-α, is a potent p53 inhibitor. p-nitro-Pifithrin-α suppresses p53-mediated TGF-β1 expression in HK-2 cells. p-nitro-Pifithrin-α inhibits the activation of caspase-3 by Zika virus (ZIKV) strains. p-nitro-Pifithrin-α attenuates steatosis and liver injury in mice fed a high-fat diet [4].non-alcoholic fatty liver disease[1][2][3].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Apoptosis >> MDM-2/p53 Signaling Pathways >> Apoptosis >> Caspase Research Areas >> Metabolic Disease
Target	Caspase-3
References	[1]. Shimizu H, Yisireyili M, Nishijima F, Niwa T. Indoxyl sulfate enhances p53-TGF-β1-Smad3 pathway in proximal tubular cells. Am J Nephrol. 2013;37(2):97-103. [2]. Zhang F, et al. Molecular signatures associated with ZIKV exposure in human cortical neural progenitors. Nucleic Acids Res. 2016 Oct 14;44(18):8610-8620. [3]. Derdak Z, et al. Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease. J Hepatol. 2013 Apr;58(4):785-91.